Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Metastatic Malignant Melanoma Therapy market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Metastatic Malignant Melanoma Therapymarket, defines the market attractiveness level of Metastatic Malignant Melanoma Therapy market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Metastatic Malignant Melanoma Therapy industry, describes the types of Metastatic Malignant Melanoma Therapy market, the applications of major players and the market size, and deeply analyzes the current situation of the global Metastatic Malignant Melanoma Therapy market and the development prospects and opportunities of Metastatic Malignant Melanoma Therapy industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Metastatic Malignant Melanoma Therapy market in Chapter 13.
By Player:
Pfizer
Bristol-Myers Squibb
Merck
Amgen
GlaxoSmithKline
Navidea
Janssen Biotech
Ono Pharmaceutical
Roche
Exelixis
Enzon Pharmaceuticals
Novartis
By Type:
Immunotherapy
Targeted Therapy
Other
By End-User:
Hospital
Medical Research Organization
Other
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Metastatic Malignant Melanoma Therapy Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Metastatic Malignant Melanoma Therapy Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Metastatic Malignant Melanoma Therapy Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Metastatic Malignant Melanoma Therapy Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Metastatic Malignant Melanoma Therapy Market Analysis and Outlook to 2022
-
7.1 Global Metastatic Malignant Melanoma Therapy Consumption (2017-2022)
-
7.2 United States Metastatic Malignant Melanoma Therapy Consumption (2017-2022)
-
7.3 Europe Metastatic Malignant Melanoma Therapy Consumption (2017-2022)
-
7.4 China Metastatic Malignant Melanoma Therapy Consumption (2017-2022)
-
7.5 Japan Metastatic Malignant Melanoma Therapy Consumption (2017-2022)
-
7.6 India Metastatic Malignant Melanoma Therapy Consumption (2017-2022)
-
7.7 South Korea Metastatic Malignant Melanoma Therapy Consumption (2017-2022)
8 Region and Country-wise Metastatic Malignant Melanoma Therapy Market Analysis and Outlook to 2028
-
8.1 Global Metastatic Malignant Melanoma Therapy Consumption Forecast (2022-2028)
-
8.2 United States Metastatic Malignant Melanoma Therapy Consumption Forecast (2022-2028)
-
8.3 Europe Metastatic Malignant Melanoma Therapy Consumption Forecast (2022-2028)
-
8.4 China Metastatic Malignant Melanoma Therapy Consumption Forecast (2022-2028)
-
8.5 Japan Metastatic Malignant Melanoma Therapy Consumption Forecast (2022-2028)
-
8.6 India Metastatic Malignant Melanoma Therapy Consumption Forecast (2022-2028)
-
8.7 South Korea Metastatic Malignant Melanoma Therapy Consumption Forecast (2022-2028)
9 Global Metastatic Malignant Melanoma Therapy Market Outlook by Types and Applications to 2022
-
9.1 Global Metastatic Malignant Melanoma Therapy Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Immunotherapy Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Targeted Therapy Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Other Consumption and Growth Rate (2017-2022)
-
9.2 Global Metastatic Malignant Melanoma Therapy Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Medical Research Organization Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Other Consumption and Growth Rate (2017-2022)
10 Global Metastatic Malignant Melanoma Therapy Market Outlook by Types and Applications to 2028
-
10.1 Global Metastatic Malignant Melanoma Therapy Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Targeted Therapy Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Other Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Metastatic Malignant Melanoma Therapy Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Medical Research Organization Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Other Consumption Forecast and Growth Rate (2022-2028)
11 Global Metastatic Malignant Melanoma Therapy Import and Export Analysis (Top 5 Countries)
-
11.1 Global Metastatic Malignant Melanoma Therapy Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Metastatic Malignant Melanoma Therapy Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Metastatic Malignant Melanoma Therapy Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Metastatic Malignant Melanoma Therapy Market Competitive Analysis
-
14.1 Pfizer
-
14.1.1 Pfizer Company Details
-
14.1.2 Pfizer Metastatic Malignant Melanoma Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Pfizer Metastatic Malignant Melanoma Therapy Product and Service
-
14.2 Bristol-Myers Squibb
-
14.2.1 Bristol-Myers Squibb Company Details
-
14.2.2 Bristol-Myers Squibb Metastatic Malignant Melanoma Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Bristol-Myers Squibb Metastatic Malignant Melanoma Therapy Product and Service
-
14.3 Merck
-
14.3.1 Merck Company Details
-
14.3.2 Merck Metastatic Malignant Melanoma Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Merck Metastatic Malignant Melanoma Therapy Product and Service
-
14.4 Amgen
-
14.4.1 Amgen Company Details
-
14.4.2 Amgen Metastatic Malignant Melanoma Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Amgen Metastatic Malignant Melanoma Therapy Product and Service
-
14.5 GlaxoSmithKline
-
14.5.1 GlaxoSmithKline Company Details
-
14.5.2 GlaxoSmithKline Metastatic Malignant Melanoma Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 GlaxoSmithKline Metastatic Malignant Melanoma Therapy Product and Service
-
14.6 Navidea
-
14.6.1 Navidea Company Details
-
14.6.2 Navidea Metastatic Malignant Melanoma Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Navidea Metastatic Malignant Melanoma Therapy Product and Service
-
14.7 Janssen Biotech
-
14.7.1 Janssen Biotech Company Details
-
14.7.2 Janssen Biotech Metastatic Malignant Melanoma Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Janssen Biotech Metastatic Malignant Melanoma Therapy Product and Service
-
14.8 Ono Pharmaceutical
-
14.8.1 Ono Pharmaceutical Company Details
-
14.8.2 Ono Pharmaceutical Metastatic Malignant Melanoma Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Ono Pharmaceutical Metastatic Malignant Melanoma Therapy Product and Service
-
14.9 Roche
-
14.9.1 Roche Company Details
-
14.9.2 Roche Metastatic Malignant Melanoma Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Roche Metastatic Malignant Melanoma Therapy Product and Service
-
14.10 Exelixis
-
14.10.1 Exelixis Company Details
-
14.10.2 Exelixis Metastatic Malignant Melanoma Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Exelixis Metastatic Malignant Melanoma Therapy Product and Service
-
14.11 Enzon Pharmaceuticals
-
14.11.1 Enzon Pharmaceuticals Company Details
-
14.11.2 Enzon Pharmaceuticals Metastatic Malignant Melanoma Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Enzon Pharmaceuticals Metastatic Malignant Melanoma Therapy Product and Service
-
14.12 Novartis
-
14.12.1 Novartis Company Details
-
14.12.2 Novartis Metastatic Malignant Melanoma Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 Novartis Metastatic Malignant Melanoma Therapy Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Metastatic Malignant Melanoma Therapy
-
Figure Metastatic Malignant Melanoma Therapy Picture
-
Table Global Metastatic Malignant Melanoma Therapy Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Metastatic Malignant Melanoma Therapy Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Metastatic Malignant Melanoma Therapy Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Metastatic Malignant Melanoma Therapy Consumption by Country (2017-2022)
-
Figure United States Metastatic Malignant Melanoma Therapy Consumption and Growth Rate (2017-2022)
-
Table Europe Metastatic Malignant Melanoma Therapy Consumption and Growth Rate (2017-2022)
-
Figure China Metastatic Malignant Melanoma Therapy Consumption and Growth Rate (2017-2022)
-
Figure Japan Metastatic Malignant Melanoma Therapy Consumption and Growth Rate (2017-2022)
-
Figure India Metastatic Malignant Melanoma Therapy Consumption and Growth Rate (2017-2022)
-
Figure South Korea Metastatic Malignant Melanoma Therapy Consumption and Growth Rate (2017-2022)
-
Figure Global Metastatic Malignant Melanoma Therapy Consumption Forecast by Country (2022-2028)
-
Figure United States Metastatic Malignant Melanoma Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Metastatic Malignant Melanoma Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Metastatic Malignant Melanoma Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Metastatic Malignant Melanoma Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Metastatic Malignant Melanoma Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Metastatic Malignant Melanoma Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Immunotherapy Consumption and Growth Rate (2017-2022)
-
Figure Global Targeted Therapy Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Medical Research Organization Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Immunotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Targeted Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Medical Research Organization Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Metastatic Malignant Melanoma Therapy Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Metastatic Malignant Melanoma Therapy Export by Region (Top 5 Countries) (2017-2028)
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Metastatic Malignant Melanoma Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Metastatic Malignant Melanoma Therapy Product and Service
-
Table Bristol-Myers Squibb (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb Metastatic Malignant Melanoma Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Metastatic Malignant Melanoma Therapy Product and Service
-
Table Merck (Foundation Year, Company Profile and etc.)
-
Table Merck Metastatic Malignant Melanoma Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Metastatic Malignant Melanoma Therapy Product and Service
-
Table Amgen (Foundation Year, Company Profile and etc.)
-
Table Amgen Metastatic Malignant Melanoma Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen Metastatic Malignant Melanoma Therapy Product and Service
-
Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline Metastatic Malignant Melanoma Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Metastatic Malignant Melanoma Therapy Product and Service
-
Table Navidea (Foundation Year, Company Profile and etc.)
-
Table Navidea Metastatic Malignant Melanoma Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Navidea Metastatic Malignant Melanoma Therapy Product and Service
-
Table Janssen Biotech (Foundation Year, Company Profile and etc.)
-
Table Janssen Biotech Metastatic Malignant Melanoma Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Janssen Biotech Metastatic Malignant Melanoma Therapy Product and Service
-
Table Ono Pharmaceutical (Foundation Year, Company Profile and etc.)
-
Table Ono Pharmaceutical Metastatic Malignant Melanoma Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Ono Pharmaceutical Metastatic Malignant Melanoma Therapy Product and Service
-
Table Roche (Foundation Year, Company Profile and etc.)
-
Table Roche Metastatic Malignant Melanoma Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche Metastatic Malignant Melanoma Therapy Product and Service
-
Table Exelixis (Foundation Year, Company Profile and etc.)
-
Table Exelixis Metastatic Malignant Melanoma Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Exelixis Metastatic Malignant Melanoma Therapy Product and Service
-
Table Enzon Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Enzon Pharmaceuticals Metastatic Malignant Melanoma Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Enzon Pharmaceuticals Metastatic Malignant Melanoma Therapy Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Metastatic Malignant Melanoma Therapy Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Metastatic Malignant Melanoma Therapy Product and Service
-
